BVT Bonus Zert FRE 31.12.2024/ DE000VC2L872 /
2024-12-20 7:40:54 PM | Chg.0.000 | Bid7:40:54 PM | Ask7:40:54 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
42.140EUR | 0.00% | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | - EUR | 2024-12-31 | Call |
GlobeNewswire
04-24
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
04-23
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
02-23
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
2023-09-04
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
2023-08-31
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil